Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Personal Author:
Lovegrove, Maribeth ; Hampton, Lee M. ; Budnitz, Daniel S. ; Geller, Andrew I. ;
Lovegrove, Maribeth ; Hampton, Lee M. ; Budnitz, Daniel S. ; Geller, Andrew I. ; Less -
Description:
Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.
Subject:
[+]
Analgesics, Opioid
Buprenorphine
Child, Preschool
Eating
Emergency Service, Hospital
Hospitalization
Humans
Infant
Notes From The Field

Source:
MMWR Morb Mortal Wkly Rep. 2013 ; 62(3):56.;
Pubmed ID:
23344700
Pubmed Central ID:
PMC4604875
Document Type:
Journal Article ;
Place as Subject:
United States ;
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:c33da01a4ef08a6e9b5e93806596afb9a4572c3dfe6d96d1d1a5b181db49d44d
File Type:

Supporting Files

• 56.nxml

  xml

More +